Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- OTHER: Retrospective Data Collection and Analysis
Sponsor
Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences